Valuation PT Ikapharmindo Putramas Tbk

Stocks

End-of-day quote INDONESIA S.E. 18/09/2026			5-day change	1st Jan Change
178.00 ^IDR	-0.56%		-4.30%	-20.54%

07-28	PT Ikapharmindo Putramas Tbk Reports Earnings Results for the Half Year Ended June 30, 2026	CI
04-24	PT Ikapharmindo Putramas Tbk Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2023	2024	2025
Market Cap ¹	340,302	411,058	377,364
Change	-	20.79%	-8.2%
Enterprise Value (EV) ¹	445,409	558,217	501,269
Change	-	25.33%	-10.2%
P/E	11.8x	82x	-13.1x
PBR	1.39x	1.67x	1.73x
PEG	3.87x	-1x	0x
Capitalization / Revenue	0.77x	1x	1.04x
EV / Revenue	1.01x	1.35x	1.38x
EV / EBITDA	10.6x	22x	-30.3x
EV / EBIT	14x	31.9x	-20.5x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	2.25	-	-
Rate of return	1.11%	-	-
EPS ²	17.08	2.977	-17.09
Distribution rate	13.2%	-	-
Net sales ¹	441,137	412,069	363,565
EBITDA ¹	41,844	25,345	-16,528
EBIT ¹	31,780	17,514	-24,485
Net income ¹	15,338	5,015	-28,785
Net Debt ¹	105,107	147,159	123,904
Reference price ²	202.00	244.00	224.00
Nbr of stocks (in thousands)	1,684,663	1,684,663	1,684,663
Announcement Date	29/04/24	26/03/25	16/03/26

¹IDR in Million²IDR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
PT IKAPHARMINDO PUTRAMAS TBK	-	-	-	-	17.02M
ELI LILLY AND COMPANY	32.77x	11.91x	24.15x	0.6%	1,027B
JOHNSON & JOHNSON	30.06x	6.68x	18.71x	1.99%	651B
ABBVIE INC.	33.39x	7.81x	16.15x	2.6%	467B
ROCHE HOLDING AG	19.57x	4.78x	11.84x	2.77%	350B
NOVARTIS AG	19.88x	5.19x	12.87x	3.09%	268B
ASTRAZENECA PLC	21.24x	4.38x	12.5x	2.01%	257B
AMGEN INC.	24.06x	6.34x	11.29x	2.66%	205B
NOVO NORDISK A/S	12.43x	4.52x	9.45x	4.04%	190B
GILEAD SCIENCES, INC.	-45.64x	6.64x	25.94x	2.18%	187B
Average	16.42x	6.47x	15.88x	2.44%	360.21B
Weighted average by Cap.	23.65x	7.72x	17.85x	1.99%